Thursday, February 22, 2024
Home Tags CSL – Seqirus

Tag: CSL – Seqirus

CSL’s $800 million vaccine manufacturing facility in Melbourne nears completion

CSL Seqirus has reached a major milestone in the construction of its new cutting-edge manufacturing facility for vaccine and antivenom manufacturing. 

TGA approves domestic manufacture of AstraZeneca vaccine

CSL has been given the nod by the Therapeutic Goods Administration (TGA) to commence the manufacture of the AstraZeneca COVID-19 Vaccine (ChAdOx1-S) in Australia. TGA’s...
Advertisement

Safe Direction

PP Shim

Wilsons Solar & Electrical

Featured Article

The Intelligent Manufacturing Forum: Automation pathways for Australian manufacturers

The Australian manufacturing sector is navigating increasingly rapid changes in industry dynamics as more technological advancements are adopted worldwide.